Results 91 to 100 of about 38,101 (219)
We compared the initial efficacy of denosumab (Dmab) and zoledronate (ZOL) in treatment‐naive patients with osteoporosis. This cohort study, based on TriNetX data, evaluated the risks of fractures and mortality using Kaplan–Meier survival analyses, with hazard ratios (HRs) and 95% confidence intervals (CIs).
Ko‐Hsiu Lu +2 more
wiley +1 more source
Xujuan Xu,1,* Biyu Shen,2,3,* Aixian Zhang,4 Jingwei Liu,3 Zhanyun Da,4 Hong Liu,4 Zhifeng Gu4 1Department of Nursing, Affiliated Hospital of Nantong University, 2School of Nursing, Nantong University, 3Department of Nursing, The Second Affiliated ...
Xu X +6 more
doaj
Background Ankylosing spondylitis (AS) is a subtype of arthritis from the axial spondylarthritis spectrum. Involvement of the sacroiliac joints is regarded as an early indicator of ankylosing spondylitis (AS), enabling early detection, and effective ...
Suzan Omar +2 more
doaj +1 more source
METHODS AND TECHNIQUES IN RECOVERING PATIENTS OF ANKYLOSING SPONDYLITIS [PDF]
Ankylosing spondylitis starts at the sacroiliac joint, affecting in a progressive way the spine’s joints, causing incorrect body postures and respiratory complications.
Andreea Domnica Buburuzan +1 more
doaj
ABSTRACT Background Fibromyalgia is a syndrome characterised by widespread chronic pain, which is believed to be mediated by a state of central sensitisation (CS). Based on the hypothesis that CS itself could have genetic determinants, our aim was to further explore this pathway.
Nicolas Macian +8 more
wiley +1 more source
ABSTRACT Background We aimed to investigate and characterise DILI due to approved therapies for inflammatory bowel disease (IBD). Methods Using the Drug‐Induced Liver Injury Network (DILIN) prospective study, we evaluated definite, highly likely, or probable DILI attributed to IBD therapies, including use for non‐IBD indications (but excluding ...
Harish Gopalakrishna +9 more
wiley +1 more source
Artificial Intelligence for Bone: Theory, Methods, and Applications
Advances in artificial intelligence (AI) offer the potential to improve bone research. The current review explores the contributions of AI to pathological study, biomarker discovery, drug design, and clinical diagnosis and prognosis of bone diseases. We envision that AI‐driven methodologies will enable identifying novel targets for drugs discovery. The
Dongfeng Yuan +3 more
wiley +1 more source
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail +7 more
wiley +1 more source
Background and objectives: Ankylosing spondylitis is a persistent inflammatory rheumatic condition that predominantly affects the axial skeleton. The current research aims to assess the correlation between disease activity and the C-reactive protein to ...
Avin Mariwan Mohammed Saleh +1 more
doaj +1 more source

